For example, hs-CRP levels were not considerably different between APOE genotype carriers in Moroccan patients with end-stage renal disease (ESRD) [53], and, in our study, some ε4 carriers exhibited high CRP levels. This evidence concerns the gene CRP and stage 5 chronic kidney disease.